Blinded by sFRP-1: A WNT signaling protein plays a key role in glaucoma

February 15, 2008

Glaucoma is one of the major causes of visual impairment and blindness throughout the world. A major risk factor for the disease is an increase in the pressure in the eye (intraocular pressure [IOP]). IOP is determined by the rate of production of the clear fluid in the eye and the rate at which this fluid flows out of the eye.

Although it is thought that impaired outflow of fluid from the eye causes the increased IOP in individuals with glaucoma, the precise molecular mechanisms underlying the disorder are poorly understood.

In a new study, Abbot Clark and his colleagues, at Alcon Research Ltd. in Fort Worth and the University of Iowa in Iowa City, have revealed that increased expression of the protein sFRP-1, an inhibitor of cell signaling through WNT proteins, seems to be responsible for elevated IOP in individuals with glaucoma.

The researchers found increased expression of sFRP-1 in eye tissue from patients with glaucoma. When donor human eyes were treated with sFRP-1 ex vivo, these eye tissues exhibited decreased outflow of fluids compared to untreated eyes.

Furthermore, the sFRP-1 treated donor eyes also had reduced expression of a WNT-related protein. Finally, increased IOP was observed in mice manipulated to express sFRP-1 in the eye and this was effectively resolved by treatment with an inhibitor of a downstream suppressor of WNT signaling. The authors therefore concluded that restoring WNT signaling might be a novel way to treat individuals with glaucoma.

Source: Journal of Clinical Investigation

Related Stories

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.